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component.
Methods: Polymeric PEA microspheres were prepared and loaded with
VEGF. The release of VEGF from these microspheres, in both cell culture
medium and human serum at 37C was followed over time. VEGF con-
centrations were analyzed by ELISA; biological activity of the released VEGF
was assessed using proliferation assays on human umbilical vein endo-
thelial cells (HUVECs). VEGF-loaded microspheres were investigated for
their pro-angiogenic potential in vivo, either in matrigel plugs or by
intramuscular injection after induction of hindlimb ischemia in mice.
Neovascularization was monitored by immunohistochemistry and Laser
Doppler Perfusion Imaging.
Results: Our experiments showed that VEGF remains stable and bio-
logically active during both fabrication and long-term storage of the mi-
crospheres. After re-suspension in either cell culture medium or human
serum, VEGF is released from the microspheres. An initial burst release
over 48 hours is followed by a gradual, sustained release over 2 weeks. The
released VEGF was able to induce proliferation of HUVECs with virtually no
loss of biological activity. In vivo, microspheres containing approximately
15 ng VEGF were able to induced angiogenesis similar to 250 ng of un-
protected VEGF in a matrigel plug assay in mice. After induction of hindlimb
ischemia, both VEGF and VEGF-loaded microspheres show a comparable
increase in blood ﬂow recovery. Immunohistochemical analyses however
show a stronger increase in the number of collateral arteries in the
adductor muscles of mice treated with VEGF loaded microspheres
compared to free VEGF.
Conclusion: VEGF can be loaded into polymeric PEA microspheres and
stored without loss of biological activity. Under physiological conditions, a
burst of VEGF is released over 48 hours, followed by sustained release of
VEGF over 2 weeks. VEGF-loaded microspheres showed an over tenfold
increase in angiogenic potential compared to free VEGF in vivo in matrigel
plugs. Furthermore the increase in number of collateral arteries in the
adductor muscles of mice subjected to hindlimb ischemia suggests a
beneﬁcial effect of sustained release of VEGF.
RCT Comparing the Long-term Results of UGFS, EVLA and Open
Surgery in the Treatment of GSV Reﬂux
S. Vähäaho, A. Albäck, K. Halmesmäki, O. Mahmoud, E. Saarinen,
M. Venermo
Vascular Surgery, University of Helsinki and Helsinki University Hospital, Helsinki,
Finland
Introduction: As options for open surgery in the treatment of great
saphenous vein (GSV) reﬂux, both UGFS (ultrasound guided foam sclero-
therapy) and EVLA (endovenous laser) have been used for years, but the
long-term results compared to open surgery are still unclear. In the current
study we analyzed the 5 year results of a RCT comparing UGFS, EVLA and
Surgery in the treatment of GSV reﬂux and varicose veins.
Methods: We randomized 233 patients from 2 hospitals who had
symptomatic GSV reﬂux in one leg for UGFS, EVLA or open surgery (ligating
and stripping the GSV). In total 196 patients from our hospital were
included and treated during 2008e2010. In EVLA and Surgery groups local
phlebectomies were done simultaneously when necessary. 5 years after the
treatment we invited all patients treated in our hospital to clinical control.
Prevalence of varicose veins, DD-ultrasound and patient satisfaction were
evaluated. Furthermore, information on the additional treatments for the
same leg during the follow up was recorded. 166 patients (UGFS n ¼ 68,
EVLA n ¼ 67, Surgery n ¼ 61) participated in the 5 year control (85% of the
patients originally treated in our hospital).
Results: After 5 years from UGFS, EVLA and Surgery, there was no reﬂux
in GSV DD in 50.8%, 89.5% and 95.9% respectively (UGFS vs. EVLA/Surgery
p < 0.01). The CEAP classiﬁcation was not signiﬁcantly associated with the
type of treatment, and neither was cosmetic satisfaction, experienced pain
caused by the varicosities, disability or the presence of oedema. However,
during the 5 year period 15.3% of the patients in the UGFS group had
gotten additional treatment (most often laser ablation of GSV and local
phlebectomies) compared to EVLA and Surgery groups (3.3% and 4.0%
respectively, p < 0.05 compared to UGFS-group). Furthermore, at 5 yearfollow, 22.0% of the patients in the UGFS group were assigned for addi-
tional treatment compared to 6.8% in EVLA group and 8.0% in Surgery
group (p < 0.05). The odds of needing a new treatment were 5.9 times
higher if treated with UGFS compared to EVLA, EVLA having the lowest
ratio of new treatment.
Conclusion: Even though there was no difference in subjective patient
satisfaction, UGFS resulted in more additional treatments and was asso-
ciated with signiﬁcantly more fully or partially reﬂuxing GSV’s after the
treatment. Therefore, we conclude that UGFS is not as feasible as EVLA or
open surgery.
Pilot Randomised Control Trial: Neuromuscular Electrical
Stimulation in Treating Venous Disease
R. Ravikumar, K.J. Williams, A. Babber, T.R. Lane, H.M. Moore,
A.H. Davies
Imperial College London, United Kingdom
Introduction: Chronic venous disease (CVD) is a common and potentially
costly condition affecting a signiﬁcant proportion of the population. This
pilot randomised control trial investigates the effect of a neuromuscular
electrical stimulation (NMES) device that causes sequential contraction of
the foot and calf muscles in patients with CVD.
Methods: Twenty-two patients with CEAP C2-C4 venous disease
were randomised to a sham or test device. Patients were asked to use
the device for 30 minutes per day for 6 weeks. Haemodynamic mea-
surements (duplex ultrasound and laser doppler ﬂuximetry), limb vol-
ume (perometer), venous reﬁll time (digital photoplethysmography) and
quality of life outcome measures were measured at baseline and after 6
weeks.
Results: The mean age of participants was 62 years, BMI 28.6, with a
15:7 female preponderance. At week 0, there was a signiﬁcant improve-
ment in femoral vein haemodynamics (from baseline) whilst using the
device in the test compared to sham group (time averaged mean velocity
(TAMV) 102.4% versus -9.1%, p < 0.0001; volume ﬂow 107.9% versus
-3.7%, p < 0.0001; peak velocity 377.7% versus -6.7%, p < 0.0001). The
sham group demonstrated an increase in limb volume, which was pre-
vented with the use of the device in the test group (sham +2.0%,
p < 0.0001; test +0.8%; p ¼ 0.0623). There was no improvement in limb
volume in either the sham or test group over the 6 weeks (sham +0.7%,
p ¼ 0.16; test +2.3%, p ¼ 0.74). A non-statistically signiﬁcant improvement
in disease speciﬁc quality of life outcome measures (AVVQ) was observed
in the test group over the 6 weeks.
Conclusion: This trial demonstrated a signiﬁcant improvement in venous
haemodynamics and reduction in limb swelling with the test device
compared to the sham group following immediate usage. In addition, it had
a positive effect on quality of life outcome measures. The device is safe to
use as a home based adjunct in managing venous disease. Due to the small
sample size, some improvements were not statistically signiﬁcant and
subgroup analysis was not performed. Further trials are required to
determine optimal frequency of device usage and the effect on different
subgroups of patients with venous disease.
Impact of Angiosome Targeted Femorodistal Bypass Surgery on
Healing Rate and Outcome in Critical Limb Ischemia.
C. Harth, C. Randon, F. Vermassen
Ghent University Hospital, Ghent, Belgium
Introduction: 3 e10% of the worldwide population is suffering from pe-
ripheral arterial disease and 1 e3% will ultimately develop critical limb
ischemia (CLI). In the presence of long lesions, a femorodistal bypass often
is the only option to avoid major amputation and secure a better quality of
life. The angiosome concept divides the foot into six anatomic regions
(angiosomes) fed by distinct source arteries arising from the posterior
tibial, anterior tibial and peroneal arteries. This study investigates whether
bypass to the artery directly feeding the ischemic angiosome has an impact
on wound healing, major amputation rate and mortality before healing was
obtained.
Abstracts 399Methods: Retrospective analysis was performed at Ghent University
Hospital of 201 non-healing ischemic wounds requiring femorodistal bypass
surgery in 177 patients. For every patient the site of the ulcer, the type of
bypass and material was identiﬁed (autologous greater saphenous vein
(GSV), cryopreserved GSV or prosthesis). Based on this information the legs
were divided into direct revascularisation (DR) and indirect revascularisa-
tion (IR).
Results: Direct ﬂow feeding the ulcer area was achieved in 103 legs
(51%) compared with IR in 98 legs (49%). In 72% of the patients the ulcer
was located in the forefoot, 5% in the mid-foot and 23% in the hind-foot.
Revascularisation was performed to the anterior tibial artery (29%), pos-
terior tibial artery (29%), peroneal artery (24%) and dorsal pedal artery
(18%). There was no difference in comorbidity between the two groups,
nor was there any inﬂuence on wound healing rate due to these comor-
bidities. DR was not able to yield a higher healing rate or lower mortality
rate (85%, 7%) at 12 months compared to IR (79%, 6%). Major amputation
at 12 months was less likely after DR (12%), then after IR (19%). Opting for
DR, using autologous GSV led to a faster wound healing (90% at 12
months). When obliged to perform IR, using a cryopreserved GSV had a
higher healing rate (85%).
Conclusion: Revascularisation plays a crucial role in the treatment of
ischemic lower extremity wounds. Similar results were obtained with re-
gard to healing rates, limb salvage and mortality before healing after DR
compared to IR. Therefore revascularisation should not be denied to pa-
tients with in whom only indirect revascularisation can be obtained. Cry-
opreserved allografts can be a valuable alternative when no good-quality
autologous vein is available.
Long Term Results of Inframalleolar Bypass for Critical Limb
Ischaemia
E. Saarinen, P. Kauhanen, A. Albäck, M. Venermo
Department of Vascular Surgery, Helsinki University and Helsinki University
Hospital, Helsinki, Finland
Introduction: Distal peripheral arterial disease (PAD) causing critical limb
ischaemia (CLI) has become more common as a result of increasing inci-
dence of diabetes. Endovascular treatment has challenged bypass surgery
as ﬁrst line treatment in crural and foot arteries, although long term results
of these interventions are lacking. The aim of this study was to evaluate
long term results of infra-malleolar bypasses.
Methods: Three hundred and ﬁfty two infra-malleolar bypasses for CLI at
our institution between 2002e2013 were included in to this retrospective
study. Risk factors were evaluated and patency, leg salvage, survival and
amputation free survival (AFS) were assessed. All patients who were alive
without amputation were invited to clinical control and patency of grafts was
assessed using duplex ultrasound.
Results: The median follow up time 29 months (range 1 e163 months).
The median age of study population was 73 years and 67% of patients were
male. The incidence of diabetes was 69%. In majority of cases (78%) the
indication for bypass surgery was ulcer or gangrene and 18% of patients
had rest pain. All except four bypasses were performed using vein graft. At
1, 5 and 10 years primary patency was 71.2%, 58.2% and 45.3%, assisted
primary patency was 76.8%, 68.5% and 54.4%, and secondary patency was
83.2%, 78.1% and 71.9%, respectively. Popliteal artery as inﬂow artery
(n ¼ 194) was associated with superior primary (p ¼ 0.013), assisted pri-
mary (p ¼ 0.028) and secondary patency (p ¼ 0.014) compared to by-
passes originating from femoral artery (n ¼ 158). The recipient artery did
not affect patency, pedal bypasses (n ¼ 281) had equal patency compared
to plantar bypasses (n ¼ 71) (p ¼ 0.920). The leg salvage rate at 1, 5 and 10
years was 78.6%, 72.0% and 67.2%. Leg salvage rate was equal in patients
with and without diabetes (p ¼ 0.460). The respective survival and AFS
rates at 1, 5 and 10 years were 70.3%, 37.4% and 15.9% and 58.4%, 29.8%
and 12.8%.
Conclusion: Bypass to infra-malleolar arteries is durable treatment
option for distal PAD in patients with CLI. These bypasses to foot arteries
have excellent long term patency and good limb salvage rate can be
achieved both in non-diabetics and diabetics.Prognostic Signiﬁcance of Different Strategies of Angiosome
Targeted Lower Limb Revascularization
K. Spillerova, MD, F. Biancari, MD, PhD, A. Albäck, MD, PhD,
M. Venermo, MD, PhD.
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Introduction: Two different methods to deﬁne angiosome targeted revas-
cularization have been described, but no consensus exists what deﬁnition
should be used. Furthermore, in thus far published studies there is lack of
consensus as how the angiosome targeted revascularization is deﬁned. Aim
to this study is to compare the two existing strategies in patients with foot
lesions involving more than one angiosome. The main focus was to eval-
uate which one is better in predicting wound healing and leg salvage.
Methods: This study cohort comprises a total of 658 patients with
Fontaine IV foot lesions and who underwent infrapopliteal endovascular or
surgical revascularization between January 2010 and July 2013. We
compared the outcome of two angiosome targeted approaches, strategy A
targeting speciﬁcally the angiosome involved in the wound area and
strategy B targeting only the posterior tibial artery and its terminal
branches if the wound is located in forefoot and the heel. Multivariate
analysis for assessment of the impact of baseline variables on late outcome
was performed using the Cox proportional hazards method. The impact of
each strategy of angiosome targeted revascularization was adjusted for a
propensity score obtained by a non-parsimonious logistic regression.
Results: Angiosome targeted lower limb revascularization according to
strategy A was performed in 367 cases (55.8%), whereas revascularization
strategy B was performed in 198 cases (30.1%). Propensity score adjusted
analysis showed that the approach of angiosome targeted revascularization
in strategy A was associated with signiﬁcantly better wound healing and leg
salvage rates, whereas the strategy B was associated only with signiﬁcantly
better wound healing. The prognostic ability of angiosome targeted
approach in strategy A was conﬁrmed in Cox proportional hazard analysis
as adjusted for diabetes, estimated glomerular ﬁltration rate, C-reactive
protein, revascularization method, number of affected angiosomes and
presence of intact pedal arch.
Conclusion: The approach of angiosome targeted revascularization in
strategy A was associated with signiﬁcantly higher wound healing and leg
salvage rate than non angiosome targeted revascularization and its prog-
nostic signiﬁcance was not inferior to strategy B.
Combined Infra-popliteal Angioplasty has No Advantage over
Direct Angiosomal Revascularisation.
A.L. Stimpson, U. Hanif, S. Germain, C. Chick, N. Goyal, C.P. Twine
Royal Gwent Hospital, Wales, United Kingdom
Introduction: Meta-analysis has shown direct (the artery leading directly to
the tissue loss) angiosomal re-perfusion to be superior to indirect reper-
fusion. Some units perform combined (direct and indirect i.e. open up as
many tibial vessels as possible) reperfusion of the tibial vessels. There was
inadequate data published on combined tibial angioplasty to perform
meta-analysis in 2014. Our unit performs combined infra-popliteal angio-
plasty routinely, where possible, so the aim was to assess any advantage
over traditional direct or indirect tibial angioplasty and to examine the
effect of diabetes on the angiosome model.
Methods: Analysis of consecutive infra-popliteal angioplasties over a 5
year period. Kaplan Meier survival curves were used to examine differences
between groups; p-values were corrected. Combined angioplasty was
performed routinely wherever possible.
Results: Two hundred and sixteen tibial angioplasties were performed.
24.5% underwent combined revascularisation, 52.3% direct and 23.1% in-
direct. There was a signiﬁcant improvement in amputation free survival
(Hazard Ratio HR ¼ 1.652, p ¼ 0.019) in the direct and combined groups
over indirect revascularisation. However, there was no improvement in
wound healing (HR ¼ 1.163, p ¼ 0.117.) The direct vs. combined
